Evidence map›Paper›PMID 40990377›Full record

ArticleACS applied materials & interfaces2025

Hybrid Silver-Silica and Organic Biocide Systems in PVC: Enhanced Antiviral Performance against SARS-CoV-2.

Daniel J da Silva, Guilherme B Gramcianinov, Vanessa B Malaquias, Pamela Z Jorge, Cecilia Gonsales, Eduardo W A Pereira, Leice G Amurin, Mário Hiroyuki Hirata, Caroline C Augusto, Bruno L Batista and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Daniel J da SilvaCenter for Engineering, Modeling and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil.
Guilherme B GramcianinovCenter for Engineering, Modeling and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil.
Vanessa B MalaquiasDepartment of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Professor Lineu Prestes, 580, São Paulo, SP CEP 05508-900, Brazil.
Pamela Z JorgeCenter for Engineering, Modeling and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil.
Cecilia GonsalesCenter for Engineering, Modeling and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil.
Eduardo W A PereiraDepartment of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Professor Lineu Prestes, 580, São Paulo, SP CEP 05508-900, Brazil.
Leice G AmurinCenter for Engineering, Modeling and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil.
Mário Hiroyuki HirataDepartment of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Professor Lineu Prestes, 580, São Paulo, SP CEP 05508-900, Brazil.
Caroline C AugustoCenter for Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil.
Bruno L BatistaCenter for Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil.
Beatriz B AlvesBR Goods Indústria e Comércio de Produtos Hospitalares, R. Antônio Barnabé, 1398, Indaiatuba, SP CEP: 13347-340, Brazil.
Luciano A BuenoCenter for Engineering, Modeling and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil.
Danilo J CarastanCenter for Engineering, Modeling and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil.ORCID 0000-0002-6883-5894
Mathilde ChampeauCenter for Engineering, Modeling and Applied Social Sciences (CECS), Federal University of ABC (UFABC), Av. dos Estados, 5001, Santo André, SP CEP 09210-580, Brazil.ORCID 0000-0003-3108-2240

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poly(vinyl chloride) (PVC) is widely used in biomedical devices and hospital infrastructure. In light of emerging pathogens such as SARS-CoV-2, there is a growing need for PVC materials with intrinsic antiviral properties. This study presents an effective strategy to develop antiviral PVC nanocomposites by incorporating silver-silica (Ag/SiO

Indexed as

Antiviral AgentsDisinfectantsMetal NanoparticlesNanocompositesPolyvinyl ChlorideSilicon DioxideSilverAnimalsChlorocebus aethiopsCOVID-19HumansPyridinesSARS-CoV-2Vero CellsAntiviral AgentsDisinfectantsPolyvinyl ChloridePyridinesSilicon DioxideSilverhybrid nanoparticlesorganic biocidespoly(vinyl chloride)SARS-CoV-2silverSiO2

Identifiers

PMID40990377
PMCPMC12516676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.